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A simple and Useful predictive 
Assay for evaluating the Quality 
of Isolated Hepatocytes for 
Hepatocyte transplantation
Muneyuki Matsumura1, takehiro Imura2, Akiko Inagaki2, Hiroyuki ogasawara1, 
Kengo Fukuoka1, Ibrahim Fathi2, shigehito Miyagi1, Kazuo ohashi3, Michiaki Unno  1, 
takashi Kamei1, susumu satomi1 & Masafumi Goto1,2
No optimal assay for assessing isolated hepatocytes before hepatocyte transplantation (Htx) has 
been established, therefore reliable and rapid assays are warranted. Isolated rat hepatocytes were 
dipped in a water bath (necrosis model), and were also cultured with okadaic acid (apoptosis model) or 
vehicle, followed by cellular assessment including trypan blue exclusion (tBe) viability, ADp /Atp ratio, 
plating efficiency (PE), DNA quantity and ammonia elimination. Hepatocytes were transplanted into 
the liver of analbuminemic rats, subsequently engraftment was assessed by serum albumin and the 
histology of transplanted grafts. In the necrosis model, the ADp/Atp ratio was strongly and negatively 
correlated with the tBe (R2 = 0.559, P < 0.001). In the apoptosis model, the ADP/ATP ratio assay, PE, 
DNA quantification and an ammonia elimination test clearly distinguished the groups (P < 0.001, 
respectively). The ADP/ATP ratio, PE and DNA quantity were well-correlated and the ammonia 
elimination was slightly correlated with the transplant outcome. tBe could not distinguish the groups 
and was not correlated with the outcome. the ADp/Atp ratio assay predicted the transplant outcome. 
PE and DNA quantification may improve the accuracy of the retrospective (evaluations require 
several days) quality assessment of hepatocytes. The ADP/ATP ratio assay, alone or with a short-term 
metabolic assay could improve the efficiency of HTx.
The first experimental attempt at whole-liver transplantation was initiated in the mid-1950s and the first success-
ful clinical liver transplantation in humans was reported in 19631. Liver transplantation has since become the 
most successful treatment for the management of end-stage liver disease and acute liver failure but donor short-
age is an urgent issue to be solved. The number of patients waiting for a liver transplantation greatly outnumbers 
the available donors. Even with the expansion to include marginal donors and recent advances in surgical tech-
niques (i.e., split-liver and living-related liver donor grafts), there has only been a small increase in the number of 
donors2. Thus, cell-based therapies have been proposed as a solution to some of these issues.
Hepatocyte transplantation (HTx) has been performed as an alternative to liver transplantation to treat lethal 
acute liver failure3,4 and some liver-based inborn errors of metabolism5,6. The HTx procedure has several advan-
tages over liver transplantation: (1) HTx (simple injection of isolated hepatocytes into the liver or spleen of the 
recipients without general anesthesia/laparotomy) is far less invasive than liver transplantation and severely ill 
patients can be treated with relatively little risk; (2) HTx can be performed repeatedly; (3) hepatocytes from one 
donor liver may be transplanted into multiple recipients, expanding the donor pool; and (4) the costs should be 
lower compared to liver transplantation. Despite positive reports and the presumed advantages of clinical HTx, 
the current literature only includes 143 cases7–9. Many challenges remain before HTx can be conducted as a rou-
tine clinical treatment.
The poor engraftment of transplanted hepatocytes is one such problem3,7–9. Since the first case of clinical 
human HTx in 199210, HTx has been more successful in animal experiments than in the clinical setting. In many 
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clinical cases, sustained benefits have not been observed; in some cases, HTx had no observable benefit3. Poor 
engraftment may be partly attributed to the induction of apoptosis due to the suboptimal quality of transplanted 
hepatocytes11,12. With the current donor shortage, the main tissue sources are marginal quality livers (i.e., stea-
totic livers, livers from elderly donors, and livers donated after cardiac death that are deemed unsuitable for liver 
organ transplantation)13–16. However, hepatocytes isolated from steatotic livers show low viability and a poor 
function17,18, the quality of hepatocytes isolated from older donors is highly variable19, and the viability of hepat-
ocytes from livers donated after cardiac death is low and is well-correlated with the warm ischemic time20, clearly 
indicating that the quality of isolated hepatocytes is a limiting factor for HTx.
Trypan blue exclusion (TBE) is the only established method for evaluating the hepatocyte quality before trans-
plantation in the clinical setting19,21. TBE is routinely performed at the end of isolation and before transplantation. 
TBE reflects the viability based on the membrane integrity and is a simple and rapid method. However, the corre-
lation between TBE viability and the clinical outcomes of HTx is unclear19,22–25. In the laboratory setting, studies 
of short-term drug metabolism and long-term cultured hepatocytes are commonly used to evaluate the quality 
of transplanted hepatocytes26–28. However, considering the fragility of isolated hepatocytes29, these assays require 
relatively too much time to assess the quality of grafts before HTx in the clinical settings; optimal methods must 
be established.
The quality assessment of graft cells is one of the key issues in the success of pancreatic islet transplantation, 
which has become an alternative treatment for diabetic patients30–33. We previously noted that an adenosine 
diphosphate (ADP)/adenosine triphosphate (ATP) ratio assay of the isolated pancreatic islets was useful for pre-
dicting the clinical outcome of pancreatic islet transplantation31,34–38. In contrast, in the field of HTx, no quality 
assay that is correlated with the outcome of HTx in an in vivo model has been developed, whereas several novel 
assays have been correlated with TBE viability assays23,26.
We aimed to establish a rapid predictive assay for evaluating the quality of isolated hepatocytes for HTx. We 
investigated the ADP/ATP ratio assay and the conventional hepatocyte quality assays (including TBE, plating 
efficiency [PE], deoxyribonucleic acid [DNA] quantification and an ammonia elimination test) to examine factors 
associated with the outcome of HTx using an in vivo analbuminemic model.
Results
Correlation between tBe viability and ADp/Atp ratio in the necrosis model. Heating caused 
membrane destruction and necrosis in hepatocytes, and subsequently resulted in hepatocytes with variable TBE 
viability. The ADP/ATP ratio was strongly and negatively correlated with TBE viability (R2 = 0.559, P < 0.001,). 
However, our data also suggested that the ADP/ATP ratio of hepatocytes (<0.12; corresponding to a TBE viability 
of >60%) was not correlated with TBE viability (R2 = 0.178, P = 0.17) (n = 12) (Fig. 1).
evaluation of the hepatocyte viability in the apoptosis model by tBe and the ADp/Atp ratio 
assay. To reveal the difference of sensitivity against apoptotic hepatocytes, we evaluated TBE viability and 
ADP/ATP ratio of hepatocytes in the two groups. The TBE viability of the Okadaic acid (OA) and control groups 
was 75.98 ± 3.59% and 74.93 ± 3.50%, respectively (n = 18). In terms of TBE viability, no significant difference 
was observed between the two groups (P = 0.582) (Fig. 2A). In contrast, the ADP/ATP ratio of the OA group was 
significantly higher than that of the control group (0.150 ± 0.060 vs. 0.080 ± 0.036%, n = 18, P < 0.001) (Fig. 2B).
Verification of the apoptotic hepatocytes in the apoptosis model by tUNeL staining and 
flow cytometry. Terminal deoxynucleotidyl transferase-mediated uridine triphosphate nick end labeling 
(TUNEL) staining and flow cytometry were used to quantify the proportions of apoptotic hepatocytes in the 
two groups. The proportion of TUNEL-positive hepatocytes in the OA group was significantly higher than that 
of the control group (10.10 ± 3.76% vs. 5.20 ± 2.36%, n = 8, P = 0.028) (Fig. 3A,B). The proportion of Annexin 
V+/7-AAD−(apoptotic cells) hepatocytes in the OA group was also significantly higher than that in the control 
group (5.00 ± 1.89 vs. 1.60 ± 0.54%, n = 8, P < 0.001), suggesting that OA could effectively induce early-phase 
apoptosis in isolated hepatocytes (Fig. 3C,D).
Figure 1. Correlation between trypan blue exclusion (TBE) viability and the ADP/ ATP ratio in the necrosis 
model The ADP/ATP ratio was strongly and negatively correlated with TBE viability (R2 = 0.559, P < 0.001). 
However, our data suggested that the ADP/ATP ratio of hepatocytes of <0.12 (corresponding to TBE viability 
of > 60%) did not correlate with TBE viability (R2 = 0.178, P = 0.172) (n = 12).
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evaluation of the hepatocyte viability and function in the apoptosis model by conventional 
assays. To investigate whether the conventional assays could effectively distinguish the OA group from 
the control group, the viability and function in the two groups were examined by PE, DNA quantification and 
Figure 2. Evaluation of the hepatocyte viability in the apoptosis model by TBE and the ADP/ATP ratio 
assay. (A) The TBE viability of the OA (dotted bar, 75.98 ± 3.59%, n = 18) and control groups (left hatched 
bar, 74.93 ± 3.50%, n = 18). No significant difference was observed between the OA and control groups. (B) 
The ADP/ATP ratio of the OA group (dotted bar, 0.150 ± 0.060, n = 18) and control group (left hatched bar, 
0.080 ± 0.036, n = 18). *P < 0.001 in OA vs. control groups.
Figure 3. Verification of the apoptotic hepatocytes in the apoptosis model by TUNEL staining and flow 
cytometry. (A) Representative images of TUNEL-staining of the OA and control groups. The nuclei of apoptotic 
cells were darkly stained and were defined as TUNEL-positive (arrows) (original magnification: 400×, scale 
bars: 100 μm). (B) The proportion of TUNEL-positive cells in the OA (dotted bar, 10.10% ± 3.76, n = 8) and 
control groups (left hatched bar, 5.20% ± 2.36, n = 8). *P < 0.05 in OA vs. control. (C) The percentage of events 
in the early apoptotic (Annexin V+/7-AAD−) and late apoptotic (Annexin V+/7-AAD+) cells are indicated in 
the schematic illustration. (D) The proportion of Annexin V+/7-AAD− cells in the OA (dotted bar, 5.0 ± 1.89%, 
n = 8) and control groups (left hatched bar, 1.6 ± 0.54%, n = 8). *P < 0.001 in OA vs. control groups.
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an ammonia elimination test. The PE of the OA group was significantly lower than that of the control group 
(9.72 ± 3.43 vs. 56.13 ± 5.11%, n = 8, P < 0.001) (Fig. 4A). Likewise, the DNA quantity at 5 days after the plating of 
hepatocytes in the OA group was significantly lower than that of the control group (5.65 ± 1.92 vs. 9.76 ± 1.43 μg, 
n = 8, P < 0.001) (Fig. 4B), while the remaining ammonia concentration at 1 h in the OA group was significantly 
higher than that in the control group (49.00 ± 7.22 vs. 37.91 ± 4.06%, n = 8, P < 0.001). No significant difference 
was observed in the concentrations at the other time points (2 h; P = 0.43, 3 h; P = 0.22, respectively) (Fig. 4C).
the in vivo evaluation of transplanted hepatocytes. To examine the correlation between several pre-
diction assays and the in vivo engraftment efficiency of the transplanted hepatocytes, serum albumin levels were 
quantified on days 0, 14 and 28 after HTx in analbuminemic rats. The serum albumin levels of the OA group 
(Day 0: 6.99 ± 0.92 μg/ml, Day 14: 7.54 ± 0.74 μg/ml and Day 28: 8.51 ± 1.24 μg/ml, respectively) were signifi-
cantly lower than those of the control group (Day 0: 7.05 ± 0.82 μg/ml, Day 14: 30.10 ± 17.64 μg/ml and Day 28: 
48.26 ± 38.76 μg/ml, respectively) (P = 0.001) (Fig. 5). Although the number of albumin-positive hepatocytes in 
the OA group (0.063 ± 0.053 cells/mm2) tended to be lower in comparison to the control group (0.144 ± 0.121 
cells/mm2), the difference was not statistically significant (P = 0.10) (Fig. 6A). In terms of TUNEL-positive hepat-
ocytes, no significant difference was observed between the OA and control groups on day 28 after HTx (Fig. 6B). 
By contrast, TUNEL-positive hepatocytes in the OA group were significantly higher than that of the control group 
(4.136 ± 2.311 vs. 2.769 ± 1.494 cells/mm2, n = 7, P = 0.015) at 90 min after HTx.
Discussion
Our findings revealed that the ADP/ATP ratio of isolated hepatocytes, but not the TBE viability—which is rou-
tinely used as quality assay—was correlated with the outcomes of HTx in an in vivo model. This is consistent with 
previous reports which showed that TBE viability measurements were not conclusive enough to predict the out-
come of HTx, as there was no correlation between the in vitro TBE viability of hepatocytes and the graft function 
after HTx19,25. Both PE and DNA quantification assays were also well-correlated with the in vivo performance 
of the transplanted hepatocyte grafts. Even in the early phase (1 h) of the ammonia elimination assay, a slight 
tendency toward correlation with the transplant outcome was observed. To the best of our knowledge, this is the 
first report to show that the results of in vitro quality assays of isolated hepatocytes before HTx are well-correlated 
with their engraftment in vivo.
Figure 4. Evaluation of the hepatocyte viability and function in the apoptosis model by conventional assays. 
(A) PE of the OA (dotted bar, 9.72 ± 3.43%, n = 8) and control groups (left hatched bar, 56.13 ± 5.11%, 
n = 8). *P < 0.001 in OA vs. control. (B) DNA quantity at 5 days after the plating of the OA (dotted bar, 
5.65 ± 1.92 μg, n = 8) and control groups (left hatched bar, 9.76 ± 1.43 μg, n = 8). *P < 0.001 in OA vs. control. 
(C) The remaining ammonia concentration at 1, 2 and 3-h in the OA (solid line, 49.0 ± 7.22, 9.43 ± 4.34 and 
3.66 ± 2.45%, respectively, n = 8) and control groups (dashed line, 37.91 ± 4.06, 7.47 ± 1.77 and 5.60 ± 2.76%, 
respectively, n = 8). *P < 0.001 at 1-h in OA vs. control.
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HTx shares many aspects with pancreatic islet transplantation, which is currently regarded as a treatment 
option for severe diabetes32. Considering the similarity between HTx and pancreatic islet transplantation, a num-
ber of research experiences based on pancreatic islet transplantation could help to achieve good outcomes in 
HTx. In the HTx, no assay to predict in vivo engraftment before transplantation has been established. In pan-
creatic islet transplantation, we previously reported that the ADP/ATP ratio of pancreatic islets was strongly 
correlated with the results of islet transplantation31. In that study, we showed that the ADP/ATP ratio, but not the 
results of current standard quality assays, was correlated with the transplant outcome in diabetic rodents. This 
is presently considered to be one of the most reliable assays to predict the outcome of clinical pancreatic islet 
transplantation39,40. Hence, in the present study, the ADP/ATP ratio was used to assess the quality of isolated 
hepatocytes and fruitful results were obtained.
Previous studies showed that the poor engraftment of transplanted hepatocytes was closely related to the 
apoptotic state of hepatocyte grafts11,12. Thus, we created a model of early-phase apoptosis using OA, a fatty acid 
isolated from the sea sponge (Halichondria okadaii), a specific inhibitor of the serine/threonine protein phos-
phatases (PP) 2A and PP1 that causes the cessation of cell cycle progression41, and which was also shown to 
induce apoptosis in various mammalian tumor cells42,43 and isolated rat hepatocytes42,44. In this model, TBE could 
not detect any differences between the OA and control groups, while the ADP/ATP ratio assay clearly identi-
fied differences in the hepatocyte quality between the two groups (Fig. 2A,B). In the apoptosis model, TUNEL 
staining and flow cytometry showed that OA group had a significantly higher fraction of early-state apoptotic 
hepatocytes (Fig. 3A–D). These data confirmed that the ADP/ATP ratio assay could discriminate between the two 
groups during early-phase apoptosis. This is most likely explained by the fact that TBE can only detect membrane 
Figure 5. The in vivo evaluation of the transplanted hepatocytes from the OA and control groups. The serum 
albumin levels of the OA and control groups on days 0, 14 and 28 were as follows: OA group, 6.99 ± 0.92, 
7.54 ± 0.74, 8.51 ± 1.24 μg/ml, respectively; control group, 7.05 ± 0.82, 30.10 ± 17.64, 48.26 ± 38.75 μg/ml, 
respectively. *P < 0.05 in OA vs. control.
Figure 6. The immunohistochemical analysis of the transplanted hepatocytes from the OA and control 
groups. (A) The number of albumin-positive hepatocytes in the OA (0.063 ± 0.053 cells/mm2, n = 8) and 
control groups (0.144 ± 0.121 cells/mm2, n = 8). (B) The number of TUNEL-positive hepatocytes in the OA 
(0.328 ± 0.179 cells/mm2, n = 8) and control groups (0.368 ± 0.216 cells/mm2, n = 8) on day 28, and (C) in the 
OA (4.136 ± 2.311 cells/mm2, n = 8) and control groups (2.769 ± 1.495 cells/mm2, n = 8). *P = 0.015 in the OA 
vs. control groups at 90 min after Htx.
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destruction and cannot detect the apoptotic hepatocytes. In contrast, the ADP/ATP ratio assay detects both apop-
totic and necrotic hepatocytes with relatively high sensitivity. We also investigated the conventional assays in 
this apoptosis model. The PE and DNA quantity of the OA group were significantly lower in comparison to the 
control group. The remaining ammonia concentration of the OA group at 1 h was also significantly higher than 
that of the control group; however, the difference was relatively small (Fig. 4A–C). PE and DNA quantification 
can examine the long-term adherence activity of isolated hepatocytes, and the ammonia elimination test could 
examine the short-term drug metabolism. One possible explanation for the difference in the data between the 
long-term adherence activity and the short-term drug metabolism is that the apoptotic hepatocytes may lead 
to necrosis over a shorter time than we had expected. Although the results of PE and the DNA quantity were 
well-correlated with the HTx outcome, several days are required before both evaluations can be completed. Given 
that the isolated hepatocytes are fairly fragile29, these assays are not practical for the clinical setting. Alternatively, 
they may be effective for increasing the accuracy of quality assessment of isolated hepatocytes retrospectively in 
the research setting. In contrast, both the ADP/ATP ratio and ammonia elimination assays are simple techniques 
that can rapidly assess the quality of isolated hepatocytes before HTx. In addition, the ADP/ATP ratio assay 
has several advantages: only a limited number of hepatocytes are required (5 × 104); rapidity (25 min); ease of 
performance using an established commercial kit; and only standard laboratory equipment is required. Notably, 
the ADP/ATP ratio assay is remarkably simple and objective in comparison to PE and DNA quantification. The 
simplicity and objectivity of the ADP/ATP ratio assay make it suitable for use as a predicting assay in the clinical 
setting.
In the necrosis model, a strong and negative correlation between the TBE viability and ADP/ATP ratio was 
seen. However, the data also show that the ADP/ATP ratio of hepatocytes <0.12 (corresponding to TBE viability 
>60%) was not correlated with the TBE viability (Fig. 1), suggesting that the TBE was better for confirming 
hepatocyte viability in the necrosis model. This is most likely explained by the fact that both ADP and ATP were 
depleted in the completely destroyed hepatocytes. Therefore, in other word, the ADP/ATP ratio may be particu-
larly useful to predict transplant outcome especially for hepatocytes with small to middle damages.
It is difficult to define the clinical success of HTx. In the present study, analbuminemic rats were used for the 
in vivo assessment of HTx, since this model shows similarities to liver-based inborn errors of metabolism. More 
importantly, it allows for the effectiveness of engraftment to be quantified. The data indicated that the ADP/ATP 
ratio was well-correlated with the engraftment of transplanted hepatocytes. In albumin staining, the recipient 
liver transplanted from the OA group tended to have less engraftment than the control group; however, the result 
was not statistically significant. TUNEL staining revealed no significant differences between the groups. This 
is most likely because the apoptotic hepatocytes in the OA group had already disappeared at the time of tissue 
retrieval. It is speculated that hepatocytes, even at an early phase of apoptosis, are susceptible to cell death due to 
the inflammation induced by HTx. Thus, one can expect that the highly-sensitive detection of early-phase apop-
totic hepatocytes before transplantation would be a powerful tool for predicting the outcomes of HTx. In fact, the 
present study clearly indicated that the ADP/ATP ratio assay could effectively predict the in vivo performance of 
the transplanted hepatocytes by detecting the proportion of early-phase apoptotic hepatocytes, which can never 
be discriminated by TBE.
The ADP/ATP ratio assay could accurately detect early-phase apoptotic hepatocytes, is a simple and useful 
assay that can rapidly predict the outcome of HTx. We propose that the ADP/ATP ratio assay, alone or in com-
bination with metabolic functional assay (i.e., the ammonia elimination test) might contribute to improving the 
efficiency of clinical HTx. This will be validated by further clinical studies using human hepatocytes.
Materials and Methods
Animals. Livers were obtained from male inbred F344/NSLc rats (age: 9–10 weeks; weight 180–220 g; Japan 
SLC Inc., Shizuoka, Japan). The analbuminemic rats (age: 8–10 weeks; weight 160–220 g) were provided by Prof 
Yuji Nishikawa (Asahikawa Medical College) and were bred at Tohoku University. These analbuminemic rats had 
a congeneic background to the donor rats45. All rats were maintained on 12-h light/dark cycle with ad libitum 
access to food and water. All animals were handled according to the Guide for the Care and Use of Laboratory 
Animals46, and the guidelines for animal experiments at Tohoku University. The experimental protocol of the 
present study (protocol ID: 2015 NICHe-Animal-001) was approved by the animal experimental committee in 
the Tohoku University.
Rat hepatocyte isolation. Rat hepatocytes were isolated and purified using a modified two-step colla-
genase perfusion technique as previously described47. The isolated hepatocytes were suspended in hepatocyte 
medium (HM) based on Dulbecco’s modified Eagle’s medium (Sigma-Aldrich) supplemented with 10% fetal 
bovine serum, glutamine, penicillin, streptomycin and 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid. The 
yield and viability of hepatocytes were determined by TBE.
trypan blue exclusion. The hepatocyte yield and viability were determined by TBE. For this analysis, cell 
suspension (50 μl) was mixed with 0.4% Trypan Blue (50 μl; Gibco, Waltham, MA, USA). The numbers of dead 
(blue) and living (white) cells were scored under light microscopy in a Burker chamber (Erma Inc., Tokyo, Japan). 
TBE viability was expressed as the percentage of living cells in comparison to the total number of cells.
the ADp/Atp ratio assay. An ApoSENSOR ADP/ATP Ratio Bioluminescent Assay kit (Biovision, San 
Francisco, CA, USA) was used to measure ADP/ATP ratio. This kit detects the ATP level based on biolumi-
nescence via a luciferase catalyzed reaction. The ADP level is measured by its conversion to ATP catalyzed by 
ADP converting enzyme. We modified the manufacturer’s instructions and optimized the protocol to specifically 
measure the viability of hepatocytes. Briefly, 5 × 104 hepatocytes were suspended in a single tube, then mixed with 
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nucleotide releasing buffer (200 μl) for 10 min at room temperature. Thereafter, ATP monitoring enzyme (10 μl) 
was added to the solution, and the ATP level was measured using a GloMax-20/20 Luminometer (Promega, 
Madison, WI, USA) and expressed as the number of relative light units (RLU). After 10 min, the ADP in the solu-
tion was converted to the ATP by adding of ADP converting enzyme (10 μl), and the RLU was measured imme-
diately before and after 5 min of conversion. Subsequently, the ADP/ATP ratio of the hepatocytes was calculated 
as (C-B)/A, where A is the RLU for ATP, B is the RLU of ATP immediately before conversion from ADP, and C is 
the RLU of ATP at 5 min after conversion from ADP; the evaluation was completed in 25 min.
Induction of necrosis by heating. We evaluated the efficacy of the ADP/ATP ratio assay in assessing 
hepatocyte viability in a necrosis model. Immediately after hepatocyte isolation, 2.5 ml of suspended hepatocytes 
(5 × 105 cells/ml) was placed in a single tube and dipped in a 60 °C water bath for 2 or 3.5 min. Then, aliquots of 
suspension were used for TBE and the ADP/ATP ratio assay (n = 12).
Induction of apoptosis using okadaic acid. We evaluated the efficacy of ADP/ATP ratio assay in assess-
ing the viability of hepatocytes in the apoptosis model using OA (Wako, Osaka, Japan). Two milliliters of hepato-
cytes (5 × 105 cells/ml) were seeded on non-treated 35-mm petri dishes (Asahi glass, Tokyo, Japan). The cells were 
cultured in HM supplemented with 100 nmol/L OA dissolved in dimethyl sulfoxide (DMSO) (OA group), or with 
only DMSO (control group). Both of the cells were cultured for 100 min at 37 °C in a humidified atmosphere with 
95% air and 5% CO2. The final DMSO concentration was 1% in both groups. Both groups were washed twice and 
re-suspended in HM. Aliquots of each cell were used for TBE and the ADP/ATP ratio assay (n = 18).
Terminal deoxynucleotidyl transferase-mediated uridine triphosphate nick end labeling 
(tUNeL) staining. In both groups 2 ml of cells (5 × 105 cells/ml) were fixed, embedded in paraffin and pre-
pared on glass slides. TUNEL staining was performed with a TACS2 TdT DAB kit (Trevigen, Gaithersburg, MD, 
USA), according to the manufacturer’s instructions. Apoptotic cells were indicated by dark brown staining of the 
nucleus. The percentage of apoptotic cells was estimated by counting the number of the apoptotic cells in compar-
ison to the total number of cells in 10 random microscopic fields (n = 8).
Flow cytometry. Flow cytometry was performed in the two groups. Briefly, 2 ml of hepatocytes (5 × 105 
cells/ml) was washed and re-suspended in 1 ml of 1 × Binding Buffer (BD Biosciences, Franklin Lakes, NJ, USA) 
and stained with Annexin V (BD Biosciences) and 7-AAD (BD Biosciences) for 15 min in the dark at room tem-
perature. Each cell was analyzed on an Accuri C6 Flow Cytometer (BD Biosciences); 5,000 cells were acquired. 
The vital cells were Annexin V−/7-AAD−, the apoptotic cells were Annexin V+/7-AAD−, and the necrotic cells 
were Annexin V+/7-AAD+ (n = 8).
evaluation of the hepatocyte viability and function in the apoptosis model by conventional 
assays. The viability and function of the OA and control groups were examined according to the PE, DNA 
quantification and an ammonia elimination test. Two milliliters of cells from each group (5 × 105 cells/ml) was 
seeded on type I collagen-coated 35-mm petri dishes (AGC Techno Glass, Shizuoka, Japan). Each group was cul-
tured in HM at 37 °C in a humidified atmosphere with 95% air and 5% CO2. The PE was determined by counting 
the attached and unattached cells using a light microscope (×200 magnification) at 18 h after plating. The PE of 
each group was expressed as the percentage of attached hepatocytes in comparison to the total number of plated 
hepatocytes. Six fields were randomly studied for each culture dish (n = 8). The HM was changed on days 1 and 
3. DNA quantification was performed to evaluate the energy status of the cultured hepatocytes at 5 days after 
plating. The DNA content was measured using a DNA quantification kit (Primary cell, Ishikari, Japan) twice for 
each dish, as previously described (n = 8)36,48. Ammonia-load culture medium was prepared with a known con-
centration of ammonium chloride solution and Williams Medium E containing 10% fetal bovine serum, 1 μmol/L 
insulin, and 1 μmol/L dexamethasone. The concentration of ammonia was adjusted to approximately 2.2 mmol/L. 
In each group, 1 × 106 hepatocytes in 1 ml of ammonia-load culture medium were cultured using non-treated 
35-mm petri dishes for 3 h at 37 °C in a humidified atmosphere with 95% air and 5% CO2. The concentration of 
ammonia at 0, 1, 2, and 3 h was measured in 20 μl of the ammonia-load culture medium using an Amicheck Meter 
(Arkray, Inc., Kyoto, Japan). The ammonia concentration at each point was shown as the percentage in compari-
son to the concentration at 0 h (n = 8)49.
the in vivo evaluation of the transplanted hepatocytes from the oA and control groups. The 
viability and functions of the OA and control groups were examined by the in vivo albumin production. Ten mil-
lion hepatocytes from the OA and control groups were spun down and pellets (200 μl) were directly injected into 
the portal vein of analbuminemic rats using a 25-G needle with a gastight syringe (Hamilton Company, Reno, 
NV, USA) for 60 s50,51. Blood samples were taken on days 0, 14, and 28. The serum albumin levels were quantified 
using a Rat Albumin ELISA kit (AKRAL-120, Shibayagi, Gunma, Japan). On day 28, the recipients were sacrificed 
and hepatic tissues were retrieved. The right, left, quadrate and caudate lobes of each sample were prepared, and 
albumin staining was performed using anti-albumin antibodies (MP Biomedicals, Santa Ana, CA, USA) com-
bined with the VECTASTAIN ABC system (Vector Laboratories, Inc., Burlingame, CA, USA). At 90 min and day 
28 after HTx, TUNEL staining was performed on hepatic tissues using a TACS2 TdT DAB kit (Trevigen). The 
number of albumin-stained and TUNEL-positive hepatocytes in each sample was counted by microscopy and 
divided by the estimated area (n = 8).
statistical analysis. All values were expressed as the means and standard deviation. The statistical analyses 
were performed using the JMP pro 12 software program (SAS institute Inc., NC, USA). Student’s t-test was used 
for comparisons between the two groups. The serum albumin levels were analyzed by a two-way ANOVA and 
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a Tukey-Kramer test was used for post-hoc comparisons between groups. The relationship between TBE viabil-
ity and the ADP/ATP ratio in the necrosis model was analyzed with Pearson’s correlation coefficient. P values 
of < 0.05 were considered to indicate statistical significance.
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